Work

Real-world outcomes of tarlatamab across small cell carcinoma subtypes, including transformed and non-lung primary.

Year: 2026

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e23350

Authors: Andrew Vegel, Aubriannah Larson, Zoe Ryan, Lekha Yadukumar, Bradley T. Loeffler, Margaret Byrne

Institutions: University of Iowa, University of Iowa Hospitals and Clinics, University of Iowa Health Care, University of Iowa Holden Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162686447

Cites:

Cited by:

Related to: